Neurological complications in critically ill patients; septic encephalopathy, criticall illness polyneuropathy

Acta Clinica Belgica

Volumn 53, Issue 2, 1998, Pages 92-97

  Nauwynck, M ^a,b   Huyghens, L ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b NONE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; MUSCLE RELAXANT AGENT;

ARTICLE; BRAIN DISEASE; CLINICAL FEATURE; CRITICAL ILLNESS; DIAGNOSTIC APPROACH ROUTE; DIET SUPPLEMENTATION; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG CONTRAINDICATION; HISTOPATHOLOGY; MULTIPLE ORGAN FAILURE; MYOPATHY; NERVE CONDUCTION; NEUROLOGIC DISEASE; NEUROMUSCULAR JUNCTION DISORDER; PATHOGENESIS; POLYNEUROPATHY; PROGNOSIS; RESPIRATORY FAILURE; SEPSIS;

EID: 0031799302     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1080/17843286.1998.11754149     Document Type: Article

References (37)

1. Bolton CF, Young GB. Neurological complications in critically ill patients. Neurology and general medicine, second edition. Churchill Livingstone. 1996; 859-78.
2. Chedru F, Geschwind N. Writing disturbances in acute confusional states. Neuropsychologia. 1972; 10:343.
3. Plum F, Posner JB. The diagnosis of stupor and coma. 1980; 3rd Ed. FA Davis, Philadelphia.
4. Jackson AC, Gilbert JJ, Young GB, Bolton CF. The encephalopathy of sepsis. Can J Neural Sci. 1985; 12: 303.
5. Young GB, Bolton CF, Austin TW, et al. The electroen-cephalogram (EEG) in sepsis. Can J Neurol Sci. 1986; 13: 164.
6. Young GB, Bolton CF, Austin TW et al. The encephalopathy associated with septic illness. Clin Invest Med. 1990; 11: 297.
7. Bryan Young G. Neurologic complications of systemic critical illness. Neurologic Critical Care. 1995; 13:3: 645-58.
8. Du Moulin GC, Paterson D, Hedley-Whyte J, Broitman SA. E. coli peritonitis and bacteremia cause increased blood-brain barrier permeability. Brain Res. 1985; 340: 261.
9. Jeppsson B, Freund HR, Gimmon Z et al. Blood-brain barrier dysfunction in sepsis: cause of septic encephalopathy? Am J Surg. 1986; 141: 136.
10. Fernstrom JD, Wurtnian RJ. Brain serotonin content. physiological regulation by plasma neutral amino acids. Science. 1972; 178: 414.
11. Bone RC, Fischer Q, Clenimer TP et al. Sepsis syndrome a valid clinical entity. Crit Care Med. 1989; 17: 389.
12. Krueger JM, Walter J, Dinarello CA et al. Sleep-promoting effects of endogenous pyrogen (Interleukin-1). Am J Physiol. 1984; 246: R994.
13. De Sarro GB, Masuda Y, Ascioti C et al. Behavioural and ECG spectrum changes induced by intracerebral infusion of interferons and interleukin 2 in rats are antagonized by naloxone. Neuropharmacology. 1990; 29: 167.
14. Nava E, Palmer RME Moncada S. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet. 1991; 338: 1557.
15. Vincent SR, Hope BT. Neurons that say NO. Trends neurosci. 1992; 115: 108.
16. Hund EF, Fogel W, Krieger D, DeGeorgia M, Hacke W. Critical illness polyneuropathy: Clinical findings and outcomes of a frequent cause of neuromuscular weaning failure. Crit Care Med. 1996: 24, 8: 1328-33.
17. Leijten FSS, Harinck-de Weerd JE, Poortvliet DCJ, de Weerd AW. The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA. 1995; 15:274: 1221-25.
18. BoltonCF. Neuromuscular complications of sepsis. Intensive Care Med. 1993; 19: S58-S63.
19. Leijten FSS, De Weerd AW, Poortvliet DCJ, De Ridder VA, Ulrich C, Harinck-De Weerd JE. Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator. Intensive Care Med. 1996; 22: 856-61.
20. Roelofs RI.Critical illness polyneuropathy. Chest. 1991; 991: 5-6.
21. Leijten FSS, de Weerd AW. Critical illness polyneuropathy; A review of the literature, definition and pathophysiology. Clinical Neurology and Neurosurgery. 1994; 96: 10-19.
22. Op De Coul AAW, Verheul GAM, Zomer E. Critical illness polyneuropathie. Ned Tijdschr Geneesk. 1990; 134: 37.1789-94.
23. Maher J, Rutledge F, Remtulla H, Parkes A, Bernardi L, Bolton C (1995). Neuromusuclar disorders associated with failure to wean from the ventilator. Intensive Care Med. 1995; 21: 7'37-4'3.
24. Couturier JC, Robert D, Monier P. Polyneurites compliquant des séjours prolongés en réanimation.. A propos de 1! cas d'étiologic encore inconnue. Lyon Med. 1984,. 252: 247-49.
25. Witt NJ, Zochodne DW, Bolton CF, et al. Peripheral nerve function in sepsis and multiple organ failure. Chest. 1991; 99: 176-84.
26. Zochodne DW, Bolton CF, Wells GA, Glibert JJ, Hahn AF, Brown JD and Sibbald WJ (1987). Critical illness polyneuropathy, a complication of sepsis and multiple organ failure. Brain. 1982; 110: 819-42.
27. Baracos V, Rodemann HP, Dinarello CA, Goldberg AL. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (Interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. N Engl J Med. 1983; 308: 553-58.
28. Lannigan R, Austin TW, Verstrup J. Myositis and rhabdomyolysis due to staphylococcus aureus septicemia. J Infect Dis. 1984: 150: 784.
29. Gooch JL, Suchyta MR, Balbierz JM, et al. Prolonged paralysis after treatment with neuromuscular junction blocking agents. Crit Care Med. 1991; 19: 1583.
30. Op de Coul AAW, Lambregts PCLA, Koeman J, Van Puyenbroek MJE, Ter Laak HJ, Gabreels-Festen AAWM. Neuromuscular complications in patients given pavulon (pancuronium bromide) during artificial respiration. Clin Neurol Neurosurg. 1985; 87: 17.
31. Danon MJ, Carpenter. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve. 1991; 14: 1131.
32. Hirano M, Ott BR, Raps EC, Minetti C, Lennihan L, Libbey NP, Bonilla E, Hay AP. Acute quadriplegic myopathy. A complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology. 1992; 42: 2082-87.
33. Segredeo V, Caldwell JE, Matthay MA, et al. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med. 1992; 327: 524.
34. Coronel B, Mercatello A, Couturier JC, Durand, PG, Holzapfell L, Blanc PL, Robert D. Polyneuropathy: Potential cause of difficult weaning. Critical Care Medicine. 1990; 18, 5: 486-9.
35. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RMH, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis (accp/seem consensus conference). Chest. 1992; 101: 1644-55.
36. Bolton CF. Neuromuscular conditions in the intensive care unit. Intensive Care Medecine. 1996; 22: 841-3.
37. Lycklama à Nijeholt, J and Troost J. Critical illness polyneuropathy. Handbook of Clinical Neurology. 1987; 7: 575-85.